Abstract
A patient with progressive prolymphocytic leukemia (PLL) received an allogeneic stem cell transplant using a reduced intensity conditioning regimen to avoid prohibitive toxicities. Early in the post-tranplant period, a high donor-derived CD8+ count was observed. One year from transplantation, the patient was in complete remission, fully donor chimeric and with a normal performance status, suggesting that this approach may represent a useful treatment option in patients with refractory PLL.
Bone Marrow Transplantation (2001) 28, 1155–1156.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Melo JV, Catovsky D, Galton DA . The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group Br J Haematol 1986 63: 377–387
Saven A, Lee T, Schultz M et al. Major activity of cladribine in patients with de novo B cell prolymphocytic leukemia J Clin Oncol 1997 15: 37–43
Dohner H, Ho AD, Thaler J et al. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group J Natl Cancer Inst 1993 85: 658–662
Michallet M, Archimbaud E, Bandini G et al. HLA-identical sibling bone marrow tranplantation in younger paients with lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry Ann Intern Med 1996 124: 311–315
Mehta J, Powles R, Singhal S et al. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia Bone Marrow Transplant 1996 17: 371–375
Rondòn G, Giralt S, Huh Y et al. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia Bone Marrow Transplant 1996 18: 669–672
Barrett J, Childs R . Non-myeloablative stem cell transplants Br J Haematol 2000 111: 6–17
Champlin R, Khouri I, Shimoni A et al. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy Br J Haematol 2000 111: 18–29
Khouri IF, Przepiorka D, van Besian K et al. Allogeneic blood or marrow transplantation for chronic lymphocytic leukemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease Br J Haematol 1997 97: 466–473
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Castagna, L., Nozza, A., Bertuzzi, A. et al. Allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in primary refractory prolymphocytic leukemia: graft-versus-leukemia effect without graft-versus-host disease. Bone Marrow Transplant 28, 1155–1156 (2001). https://doi.org/10.1038/sj.bmt.1703309
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703309
Keywords
This article is cited by
-
Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment
Current Oncology Reports (2017)
-
Allogeneic peripheral stem-cell transplantation with reduced-intensity conditioning regimen in refractory primary B-cell prolymphocytic leukemia: a long-term follow-up
Bone Marrow Transplantation (2005)